04.05.2021 05:01:48
|
Chemours Q1 Profit Down
(RTTNews) - Chemours Co. (CC) reported that its first quarter net income declined to $96 million or $0.57 per share from $100 million or $0.61 per share in the prior year.
Adjusted earnings per share was $0.71, same with the prior year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.63 per share for the quarter. Analysts' estimates typically exclude special items.
Net sales were $1.44 billion, 10% higher than the prior-year quarter, which included a negative 1% portfolio impact from the exit of the aniline business. Analysts expected revenue of $1.4 billion for the quarter.
The company now expects to deliver 2021 Adjusted EBITDA within a range of $1.1 billion to $1.25 billion and to generate greater than $450 million of Free Cash Flow.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu The Chemours Co When Issuedmehr Nachrichten
03.11.24 |
Ausblick: The Chemours öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) | |
20.10.24 |
Erste Schätzungen: The Chemours präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) |
Analysen zu The Chemours Co When Issuedmehr Analysen
Aktien in diesem Artikel
The Chemours Co When Issued | 18,26 | -0,49% |